This suggests that in addition to regulating the SREBF1 and SREBF2 pathways, KLF6-dependent effects on ccRCC lipid metabolism may also involve PLIN2 and CPT1A. The gene discussed is CPT1A; the disease is nonpapillary renal cell carcinoma.